Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-26T07:15:55.423Z Has data issue: false hasContentIssue false

Answer

Published online by Cambridge University Press:  21 May 2015

Kirk Hollohan*
Affiliation:
St. Paul’s Hospital, Vancouver, BC

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The correct diagnosis is D. In this case, a routine electrolyte screen revealed a serum potassium of 1.7 mmol/L (normal = 3.5−5.0) and a serum phosphate of 0.39 mmol/L (0.80–1.60). Calcium, magnesium, creatine kinase and ESR (erythrocyte sedimentation rate) were normal.

Type
Diagnostic Challenge • Défi Diagnostique
Copyright
Copyright © Canadian Association of Emergency Physicians 1999

References

1.Manoukian, MA, Foote, JA, Crapo, LM.Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999;159:6016.CrossRefGoogle ScholarPubMed
2.Ferreiro, JE, Arguelles, DJ, Rams, H. JrThyrotoxic periodic paralysis. Am J Med 1986;80:14650.CrossRefGoogle ScholarPubMed
3.Ee, B, Cheah, JS.Electrocardiographic changes in thyrotoxic periodic paralysis. J Electrocardiol 1979;12:26379.CrossRefGoogle ScholarPubMed
4.Ober, KP.Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 1992;71:10920.CrossRefGoogle ScholarPubMed
5.Knochel, JP.The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 1977;137:20314.CrossRefGoogle ScholarPubMed
6.Brown, MJ, Brown, DC, Murphy, DC.Hypokalemia from beta-2 receptor stimulation by circulating epinephrine. N Engl J Med 1983;309:14149.CrossRefGoogle Scholar